Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
US6656935 | METUCHEN PHARMS | Aromatic nitrogen-containing 6-membered cyclic compounds |
Apr, 2025
(a year from now) | |
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7501409 | METUCHEN PHARMS | Preparations for oral administration |
May, 2023
(11 months ago) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
M(M-282) | Oct 18, 2025 |
New Dosing Schedule(D-140) | Sep 17, 2017 |
New Chemical Entity Exclusivity(NCE) | Apr 27, 2017 |
NCE-1 date: 27 April, 2016
Market Authorisation Date: 27 April, 2012
Treatment: Treatment of erectile dysfunction
Dosage: TABLET;ORAL